Day

December 30, 2020
Alzamend Neuro, a Tampa biopharmaceutical firm focused on developing products to treat neurodegenerative diseases and psychiatric disorders, could become the area’s next publicly traded company. Alzamend submitted a draft registration statement to the U.S. Securities and Exchange Commission on Tuesday. A public offering, subject to market conditions, is expected to follow a review by the...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases

Guidesly